A newly developed bisphosphonate, YM529, is a potent apoptosis inducer of human myeloma cells (Q31801512)

3 July 2017

title

A newly developed bisphosphonate, YM529, is a potent apoptosis inducer of human myeloma cells (English)

1 reference

3 July 2017

Takahashi R

1

1 reference

3 July 2017

Shimazaki C

2

1 reference

3 July 2017

Inaba T

3

1 reference

3 July 2017

Okano A

4

1 reference

3 July 2017

Hatsuse M

5

1 reference

3 July 2017

Okamoto A

6

1 reference

3 July 2017

Hirai H

7

1 reference

3 July 2017

Ashihara E

8

1 reference

3 July 2017

Nakagawa M

9

1 reference

3 July 2017

publication date

1 January 2001

1 reference

3 July 2017

1 reference

3 July 2017

volume

25

1 reference

3 July 2017

issue

1

1 reference

3 July 2017

page(s)

77-83

1 reference

Diphosphonates and Page's disease of bone.

3 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900087-4

7 January 2021

Efficacy of the bisphosphonate APD in the control of Paget's bone disease

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900087-4

7 January 2021

Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900087-4

7 January 2021

Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900087-4

7 January 2021

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900087-4

7 January 2021

Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900087-4

7 January 2021

Anti-myeloma activity of pamidronate in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900087-4

7 January 2021

Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900087-4

7 January 2021

In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900087-4

7 January 2021

Sensitive determination of a novel bisphosphonate, YM529, in plasma, urine and bone by high-performance liquid chromatography with fluorescence detection

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900087-4

7 January 2021

Effect of a newly developed bisphosphonate, YH529, on osteolytic bone metastases in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900087-4

7 January 2021

A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900087-4

7 January 2021

A rapid single-laser flow cytometric method for discrimination of early apoptotic cells in a heterogenous cell population.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900087-4

7 January 2021

Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900087-4

7 January 2021

Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900087-4

7 January 2021

Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environment

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900087-4

7 January 2021

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900087-4

7 January 2021

Studies on novel bone resorption inhibitors. II. Synthesis and pharmacological activities of fused aza-heteroarylbisphosphonate derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900087-4

7 January 2021

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900087-4

7 January 2021

Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900087-4

7 January 2021

Excessive bone resorption in human plasmacytomas: direct induction by tumour cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900087-4

7 January 2021

10.1016/S0145-2126(00)00087-4

Identifiers

DOI

1 reference

3 July 2017

1 reference